Optiray Ultraject (Ioversol)

Ioversol, the active ingredient in Optiray Ultraject, is an iodinated contrast agent presented as a sterile injectable solution for intra‑arterial and intravenous use. It provides radiodensity to enhance visualization of vascular structures and tissues during imaging procedures.\n\nGNH India supplies Optiray Ultraject as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Optiray Ultraject, an iodinated contrast media, is used to improve image quality in vascular and tissue imaging.\n\nAngiography: enhances visualization of arterial and venous structures during diagnostic and interventional procedures.\nComputed Tomography (CT) imaging: increases contrast between organs and vessels for clearer cross‑sectional images.\nCardiac CT: facilitates detailed assessment of coronary arteries and cardiac anatomy.

Adverse reactions may occur following administration of iodinated contrast agents.\n\nCommon Side Effects:\n- Warm sensation or flushing at the injection site\n- Metallic taste in the mouth\n- Nausea or mild vomiting\n- Headache or dizziness\n- Transient urticaria or mild skin rash\n- Mild increase in serum creatinine\n\nSerious or Rare Side Effects:\n- Anaphylactoid or severe allergic reaction\n- Acute renal failure, especially in patients with pre‑existing kidney disease\n- Seizures or neurologic disturbances\n- Hypotension or cardiovascular collapse\n- Pulmonary edema or respiratory distress\n- Cardiac arrhythmias or arrest

When using Optiray Ultraject, clinicians should observe several safety measures.\n\nAssess renal function: evaluate serum creatinine and eGFR before administration.\nScreen for iodine or contrast allergy: obtain detailed allergy history.\nUse lowest effective dose: tailor volume to imaging requirement.\nMonitor vital signs: observe patient during and after injection.\nAvoid in uncontrolled hyperthyroidism: iodine load may exacerbate condition.\nStore at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Ioversol may interact with other medicines, requiring attention to dosing and monitoring.\n\nMajor Interactions (Avoid):\n- Metformin: risk of lactic acidosis in renal impairment; consider temporary discontinuation.\n- Loop diuretics or nephrotoxic antibiotics: may increase risk of contrast‑induced nephropathy.\n- ACE inhibitors or ARBs: can potentiate renal dysfunction when combined with contrast.\n\nModerate Interactions (Monitor Closely):\n- NSAIDs: may modestly raise renal risk; monitor kidney function.\n- Thyroid hormone preparations: excess iodine can alter thyroid hormone levels; check thyroid function if needed.\n- Beta‑blockers: may mask tachycardia signs of an allergic reaction; observe hemodynamics closely.